Akero Therapeutics, Inc. (AKRO): 2 insider purchases in the last two years; 1 trade disclosed by members of Congress.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Mar 27, 2025 | Graham G. Walmsley Director | 200,000 | $43.94 | $8.8M | no history |
| Feb 7, 2025 | Graham G. Walmsley Director | 200,000 | $48.00 | $9.6M | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.
| Filed | Member | Type | Amount |
|---|---|---|---|
| Dec 12, 2022 | Christopher L. Jacobs | purchase | $1,001 - $15,000 |